According to A Latest intelligence report published by Market IntelliX, the global market for Biotech Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Biotech Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Biotech Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Monoclonal Antibodies segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Biotech Drug include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.

This report aims to provide a comprehensive study of the global market for Biotech Drug. Report Highlights:

(1) Global Biotech Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Biotech Drug market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Biotech Drug market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Biotech Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Biotech Drug segment by type and by application and regional segment by type and by application.

(6) Biotech Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Monoclonal Antibodies

Interferon

Insulin

Vaccines

Others

Market segment by application, can be divided into

Hospital

Retail Pharmacy

Other

Market segment by players, this report covers

Roche

Amgen

AbbVie

Sanofi

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

Biogen

Celltrion

Sobi

3SBIO

Changchun High Tech

Kanghong Pharma

Innovent Biologics

Gan&Lee

Tonghua Dongbao

United Laboratory

1 Market Overview

1.1 Product Overview and Scope of Biotech Drug

1.2 Global Biotech Drug Market Size and Forecast

1.3 China Biotech Drug Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Biotech Drug Share in Global Market, 2018-2029

1.4.2 Biotech Drug Market Size: China VS Global, 2018-2029

1.5 Biotech Drug Market Dynamics

1.5.1 Biotech Drug Market Drivers

1.5.2 Biotech Drug Market Restraints

1.5.3 Biotech Drug Industry Trends

1.5.4 Biotech Drug Industry Policy

2 Global Competitive Situation by Company

2.1 Global Biotech Drug Revenue by Company (2018-2023)

2.2 Global Biotech Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Biotech Drug Concentration Ratio

2.4 Global Biotech Drug Mergers & Acquisitions, Expansion Plans

2.5 Global Biotech Drug Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Biotech Drug Revenue by Company (2018-2023)

3.2 China Biotech Drug Biotech Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Biotech Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Biotech Drug Industry Chain

4.2 Biotech Drug Upstream Analysis

4.3 Biotech Drug Midstream Analysis

4.4 Biotech Drug Downstream Analysis

5 Sights by Type

5.1 Biotech Drug Classification

5.1.1 Monoclonal Antibodies

5.1.2 Interferon

5.1.3 Insulin

5.1.4 Vaccines

5.1.5 Others

5.2 By Type, Global Biotech Drug Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Biotech Drug Revenue, 2018-2029

6 Sights by Application

6.1 Biotech Drug Segment by Application

6.1.1 Hospital

6.1.2 Retail Pharmacy

6.1.3 Other

6.2 By Application, Global Biotech Drug Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Biotech Drug Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Biotech Drug Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Biotech Drug Market Size, 2018-2029

7.3 North America

7.3.1 North America Biotech Drug Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Biotech Drug Market Size Market Share

7.4 Europe

7.4.1 Europe Biotech Drug Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Biotech Drug Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Biotech Drug Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Biotech Drug Market Size Market Share

7.6 South America

7.6.1 South America Biotech Drug Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Biotech Drug Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Biotech Drug Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Biotech Drug Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Biotech Drug Market Size, 2018-2029

8.3.2 By Company, U.S. Biotech Drug Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Biotech Drug Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Biotech Drug Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Biotech Drug Market Size, 2018-2029

8.4.2 By Company, Europe Biotech Drug Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Biotech Drug Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Biotech Drug Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Biotech Drug Market Size, 2018-2029

8.5.2 By Company, China Biotech Drug Revenue Market Share, 2018-2023

8.5.3 By Type, China Biotech Drug Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Biotech Drug Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Biotech Drug Market Size, 2018-2029

8.6.2 By Company, Japan Biotech Drug Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Biotech Drug Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Biotech Drug Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Biotech Drug Market Size, 2018-2029

8.7.2 By Company, South Korea Biotech Drug Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Biotech Drug Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Biotech Drug Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Biotech Drug Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Biotech Drug Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Biotech Drug Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Biotech Drug Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Biotech Drug Market Size, 2018-2029

8.9.2 By Company, India Biotech Drug Revenue Market Share, 2018-2023

8.9.3 By Type, India Biotech Drug Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Biotech Drug Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Biotech Drug Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Biotech Drug Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Biotech Drug Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Biotech Drug Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Roche

9.1.1 Roche Company Information, Head Office, Market Area and Industry Position

9.1.2 Roche Company Profile and Main Business

9.1.3 Roche Biotech Drug Models, Specifications and Application

9.1.4 Roche Biotech Drug Revenue and Gross Margin, 2018-2023

9.1.5 Roche Recent Developments

9.2 Amgen

9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position

9.2.2 Amgen Company Profile and Main Business

9.2.3 Amgen Biotech Drug Models, Specifications and Application

9.2.4 Amgen Biotech Drug Revenue and Gross Margin, 2018-2023

9.2.5 Amgen Recent Developments

9.3 AbbVie

9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.3.2 AbbVie Company Profile and Main Business

9.3.3 AbbVie Biotech Drug Models, Specifications and Application

9.3.4 AbbVie Biotech Drug Revenue and Gross Margin, 2018-2023

9.3.5 AbbVie Recent Developments

9.4 Sanofi

9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.4.2 Sanofi Company Profile and Main Business

9.4.3 Sanofi Biotech Drug Models, Specifications and Application

9.4.4 Sanofi Biotech Drug Revenue and Gross Margin, 2018-2023

9.4.5 Sanofi Recent Developments

9.5 Johnson & Johnson

9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.5.2 Johnson & Johnson Company Profile and Main Business

9.5.3 Johnson & Johnson Biotech Drug Models, Specifications and Application

9.5.4 Johnson & Johnson Biotech Drug Revenue and Gross Margin, 2018-2023

9.5.5 Johnson & Johnson Recent Developments

9.6 Pfizer

9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.6.2 Pfizer Company Profile and Main Business

9.6.3 Pfizer Biotech Drug Models, Specifications and Application

9.6.4 Pfizer Biotech Drug Revenue and Gross Margin, 2018-2023

9.6.5 Pfizer Recent Developments

9.7 Novo Nordisk

9.7.1 Novo Nordisk Company Information, Head Office, Market Area and Industry Position

9.7.2 Novo Nordisk Company Profile and Main Business

9.7.3 Novo Nordisk Biotech Drug Models, Specifications and Application

9.7.4 Novo Nordisk Biotech Drug Revenue and Gross Margin, 2018-2023

9.7.5 Novo Nordisk Recent Developments

9.8 Eli Lilly

9.8.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position

9.8.2 Eli Lilly Company Profile and Main Business

9.8.3 Eli Lilly Biotech Drug Models, Specifications and Application

9.8.4 Eli Lilly Biotech Drug Revenue and Gross Margin, 2018-2023

9.8.5 Eli Lilly Recent Developments

9.9 Novartis

9.9.1 Novartis Company Information, Head Office, Market Area and Industry Position

9.9.2 Novartis Company Profile and Main Business

9.9.3 Novartis Biotech Drug Models, Specifications and Application

9.9.4 Novartis Biotech Drug Revenue and Gross Margin, 2018-2023

9.9.5 Novartis Recent Developments

9.10 Merck

9.10.1 Merck Company Information, Head Office, Market Area and Industry Position

9.10.2 Merck Company Profile and Main Business

9.10.3 Merck Biotech Drug Models, Specifications and Application

9.10.4 Merck Biotech Drug Revenue and Gross Margin, 2018-2023

9.10.5 Merck Recent Developments

9.11 Biogen

9.11.1 Biogen Company Information, Head Office, Market Area and Industry Position

9.11.2 Biogen Company Profile and Main Business

9.11.3 Biogen Biotech Drug Models, Specifications and Application

9.11.4 Biogen Biotech Drug Revenue and Gross Margin, 2018-2023

9.11.5 Biogen Recent Developments

9.12 Celltrion

9.12.1 Celltrion Company Information, Head Office, Market Area and Industry Position

9.12.2 Celltrion Company Profile and Main Business

9.12.3 Celltrion Biotech Drug Models, Specifications and Application

9.12.4 Celltrion Biotech Drug Revenue and Gross Margin, 2018-2023

9.12.5 Celltrion Recent Developments

9.13 Sobi

9.13.1 Sobi Company Information, Head Office, Market Area and Industry Position

9.13.2 Sobi Company Profile and Main Business

9.13.3 Sobi Biotech Drug Models, Specifications and Application

9.13.4 Sobi Biotech Drug Revenue and Gross Margin, 2018-2023

9.13.5 Sobi Recent Developments

9.14 3SBIO

9.14.1 3SBIO Company Information, Head Office, Market Area and Industry Position

9.14.2 3SBIO Company Profile and Main Business

9.14.3 3SBIO Biotech Drug Models, Specifications and Application

9.14.4 3SBIO Biotech Drug Revenue and Gross Margin, 2018-2023

9.14.5 3SBIO Recent Developments

9.15 Changchun High Tech

9.15.1 Changchun High Tech Company Information, Head Office, Market Area and Industry Position

9.15.2 Changchun High Tech Company Profile and Main Business

9.15.3 Changchun High Tech Biotech Drug Models, Specifications and Application

9.15.4 Changchun High Tech Biotech Drug Revenue and Gross Margin, 2018-2023

9.15.5 Changchun High Tech Recent Developments

9.16 Kanghong Pharma

9.16.1 Kanghong Pharma Company Information, Head Office, Market Area and Industry Position

9.16.2 Kanghong Pharma Company Profile and Main Business

9.16.3 Kanghong Pharma Biotech Drug Models, Specifications and Application

9.16.4 Kanghong Pharma Biotech Drug Revenue and Gross Margin, 2018-2023

9.16.5 Kanghong Pharma Recent Developments

9.17 Innovent Biologics

9.17.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position

9.17.2 Innovent Biologics Company Profile and Main Business

9.17.3 Innovent Biologics Biotech Drug Models, Specifications and Application

9.17.4 Innovent Biologics Biotech Drug Revenue and Gross Margin, 2018-2023

9.17.5 Innovent Biologics Recent Developments

9.18 Gan&Lee

9.18.1 Gan&Lee Company Information, Head Office, Market Area and Industry Position

9.18.2 Gan&Lee Company Profile and Main Business

9.18.3 Gan&Lee Biotech Drug Models, Specifications and Application

9.18.4 Gan&Lee Biotech Drug Revenue and Gross Margin, 2018-2023

9.18.5 Gan&Lee Recent Developments

9.19 Tonghua Dongbao

9.19.1 Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position

9.19.2 Tonghua Dongbao Company Profile and Main Business

9.19.3 Tonghua Dongbao Biotech Drug Models, Specifications and Application

9.19.4 Tonghua Dongbao Biotech Drug Revenue and Gross Margin, 2018-2023

9.19.5 Tonghua Dongbao Recent Developments

9.20 United Laboratory

9.20.1 United Laboratory Company Information, Head Office, Market Area and Industry Position

9.20.2 United Laboratory Company Profile and Main Business

9.20.3 United Laboratory Biotech Drug Models, Specifications and Application

9.20.4 United Laboratory Biotech Drug Revenue and Gross Margin, 2018-2023

9.20.5 United Laboratory Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Biotech Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Biotech Drug Market Restraints

Table 3. Biotech Drug Market Trends

Table 4. Biotech Drug Industry Policy

Table 5. Global Biotech Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Biotech Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Biotech Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Biotech Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Biotech Drug Manufacturers Product Type

Table 10. China Biotech Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Biotech Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Biotech Drug Upstream (Raw Materials)

Table 13. Global Biotech Drug Typical Customers

Table 14. Biotech Drug Typical Distributors

Table 15. By Type, Global Biotech Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Biotech Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Biotech Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Biotech Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Biotech Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Biotech Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Biotech Drug Revenue Market Share, 2018-2029

Table 22. Roche Company Information, Head Office, Market Area and Industry Position

Table 23. Roche Company Profile and Main Business

Table 24. Roche Biotech Drug Models, Specifications and Application

Table 25. Roche Biotech Drug Revenue and Gross Margin, 2018-2023

Table 26. Roche Recent Developments

Table 27. Amgen Company Information, Head Office, Market Area and Industry Position

Table 28. Amgen Company Profile and Main Business

Table 29. Amgen Biotech Drug Models, Specifications and Application

Table 30. Amgen Biotech Drug Revenue and Gross Margin, 2018-2023

Table 31. Amgen Recent Developments

Table 32. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 33. AbbVie Company Profile and Main Business

Table 34. AbbVie Biotech Drug Models, Specifications and Application

Table 35. AbbVie Biotech Drug Revenue and Gross Margin, 2018-2023

Table 36. AbbVie Recent Developments

Table 37. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 38. Sanofi Company Profile and Main Business

Table 39. Sanofi Biotech Drug Models, Specifications and Application

Table 40. Sanofi Biotech Drug Revenue and Gross Margin, 2018-2023

Table 41. Sanofi Recent Developments

Table 42. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 43. Johnson & Johnson Company Profile and Main Business

Table 44. Johnson & Johnson Biotech Drug Models, Specifications and Application

Table 45. Johnson & Johnson Biotech Drug Revenue and Gross Margin, 2018-2023

Table 46. Johnson & Johnson Recent Developments

Table 47. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 48. Pfizer Company Profile and Main Business

Table 49. Pfizer Biotech Drug Models, Specifications and Application

Table 50. Pfizer Biotech Drug Revenue and Gross Margin, 2018-2023

Table 51. Pfizer Recent Developments

Table 52. Novo Nordisk Company Information, Head Office, Market Area and Industry Position

Table 53. Novo Nordisk Company Profile and Main Business

Table 54. Novo Nordisk Biotech Drug Models, Specifications and Application

Table 55. Novo Nordisk Biotech Drug Revenue and Gross Margin, 2018-2023

Table 56. Novo Nordisk Recent Developments

Table 57. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 58. Eli Lilly Company Profile and Main Business

Table 59. Eli Lilly Biotech Drug Models, Specifications and Application

Table 60. Eli Lilly Biotech Drug Revenue and Gross Margin, 2018-2023

Table 61. Eli Lilly Recent Developments

Table 62. Novartis Company Information, Head Office, Market Area and Industry Position

Table 63. Novartis Company Profile and Main Business

Table 64. Novartis Biotech Drug Models, Specifications and Application

Table 65. Novartis Biotech Drug Revenue and Gross Margin, 2018-2023

Table 66. Novartis Recent Developments

Table 67. Merck Company Information, Head Office, Market Area and Industry Position

Table 68. Merck Company Profile and Main Business

Table 69. Merck Biotech Drug Models, Specifications and Application

Table 70. Merck Biotech Drug Revenue and Gross Margin, 2018-2023

Table 71. Merck Recent Developments

Table 72. Biogen Company Information, Head Office, Market Area and Industry Position

Table 73. Biogen Company Profile and Main Business

Table 74. Biogen Biotech Drug Models, Specifications and Application

Table 75. Biogen Biotech Drug Revenue and Gross Margin, 2018-2023

Table 76. Biogen Recent Developments

Table 77. Celltrion Company Information, Head Office, Market Area and Industry Position

Table 78. Celltrion Company Profile and Main Business

Table 79. Celltrion Biotech Drug Models, Specifications and Application

Table 80. Celltrion Biotech Drug Revenue and Gross Margin, 2018-2023

Table 81. Celltrion Recent Developments

Table 82. Sobi Company Information, Head Office, Market Area and Industry Position

Table 83. Sobi Company Profile and Main Business

Table 84. Sobi Biotech Drug Models, Specifications and Application

Table 85. Sobi Biotech Drug Revenue and Gross Margin, 2018-2023

Table 86. Sobi Recent Developments

Table 87. 3SBIO Company Information, Head Office, Market Area and Industry Position

Table 88. 3SBIO Company Profile and Main Business

Table 89. 3SBIO Biotech Drug Models, Specifications and Application

Table 90. 3SBIO Biotech Drug Revenue and Gross Margin, 2018-2023

Table 91. 3SBIO Recent Developments

Table 92. Changchun High Tech Company Information, Head Office, Market Area and Industry Position

Table 93. Changchun High Tech Company Profile and Main Business

Table 94. Changchun High Tech Biotech Drug Models, Specifications and Application

Table 95. Changchun High Tech Biotech Drug Revenue and Gross Margin, 2018-2023

Table 96. Changchun High Tech Recent Developments

Table 97. Kanghong Pharma Company Information, Head Office, Market Area and Industry Position

Table 98. Kanghong Pharma Company Profile and Main Business

Table 99. Kanghong Pharma Biotech Drug Models, Specifications and Application

Table 100. Kanghong Pharma Biotech Drug Revenue and Gross Margin, 2018-2023

Table 101. Kanghong Pharma Recent Developments

Table 102. Innovent Biologics Company Information, Head Office, Market Area and Industry Position

Table 103. Innovent Biologics Company Profile and Main Business

Table 104. Innovent Biologics Biotech Drug Models, Specifications and Application

Table 105. Innovent Biologics Biotech Drug Revenue and Gross Margin, 2018-2023

Table 106. Innovent Biologics Recent Developments

Table 107. Gan&Lee Company Information, Head Office, Market Area and Industry Position

Table 108. Gan&Lee Company Profile and Main Business

Table 109. Gan&Lee Biotech Drug Models, Specifications and Application

Table 110. Gan&Lee Biotech Drug Revenue and Gross Margin, 2018-2023

Table 111. Gan&Lee Recent Developments

Table 112. Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position

Table 113. Tonghua Dongbao Company Profile and Main Business

Table 114. Tonghua Dongbao Biotech Drug Models, Specifications and Application

Table 115. Tonghua Dongbao Biotech Drug Revenue and Gross Margin, 2018-2023

Table 116. Tonghua Dongbao Recent Developments

Table 117. United Laboratory Company Information, Head Office, Market Area and Industry Position

Table 118. United Laboratory Company Profile and Main Business

Table 119. United Laboratory Biotech Drug Models, Specifications and Application

Table 120. United Laboratory Biotech Drug Revenue and Gross Margin, 2018-2023

Table 121. United Laboratory Recent Developments

List of Figure

Figure 1. Biotech Drug Picture

Figure 2. Global Biotech Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Biotech Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Biotech Drug Market Share of Global

Figure 5. Global Biotech Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Biotech Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Biotech Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Biotech Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Biotech Drug Industry Chain

Figure 10. Monoclonal Antibodies

Figure 11. Interferon

Figure 12. Insulin

Figure 13. Vaccines

Figure 14. Others

Figure 15. By Type, Global Biotech Drug Revenue, 2018-2029, US$ Million

Figure 16. By Type, Global Biotech Drug Revenue Market Share, 2018-2029

Figure 17. Hospital

Figure 18. Retail Pharmacy

Figure 19. Other

Figure 20. By Application, Global Biotech Drug Revenue, 2018-2029, US$ Million

Figure 21. By Application, Global Biotech Drug Revenue Market Share, 2018-2029

Figure 22. By Region, Global Biotech Drug Revenue Market Share, 2018-2029

Figure 23. North America Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, North America Biotech Drug Revenue Market Share, 2018-2023

Figure 25. Europe Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country, Europe Biotech Drug Revenue Market Share, 2018-2023

Figure 27. Asia Pacific Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country/Region, Asia Pacific Biotech Drug Revenue Market Share, 2018-2023

Figure 29. South America Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. By Country, South America Biotech Drug Revenue Market Share, 2018-2023

Figure 31. Middle East & Africa Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 32. U.S. Biotech Drug Revenue, 2018-2029, (US$ Million)

Figure 33. By Company, U.S. Biotech Drug Market Share, 2018-2023

Figure 34. By Type, U.S. Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 35. By Application, U.S. Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 36. Europe Biotech Drug Revenue, 2018-2029, (US$ Million)

Figure 37. By Company, Europe Biotech Drug Market Share, 2018-2023

Figure 38. By Type, Europe Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 39. By Application, Europe Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 40. China Biotech Drug Revenue, 2018-2029, (US$ Million)

Figure 41. By Company, China Biotech Drug Market Share, 2018-2023

Figure 42. By Type, China Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 43. By Application, China Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 44. Japan Biotech Drug Revenue, 2018-2029, (US$ Million)

Figure 45. By Company, Japan Biotech Drug Market Share, 2018-2023

Figure 46. By Type, Japan Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 47. By Application, Japan Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 48. South Korea Biotech Drug Revenue, 2018-2029, (US$ Million)

Figure 49. By Company, South Korea Biotech Drug Market Share, 2018-2023

Figure 50. By Type, South Korea Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 51. By Application, South Korea Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 52. Southeast Asia Biotech Drug Revenue, 2018-2029, (US$ Million)

Figure 53. By Company, Southeast Asia Biotech Drug Market Share, 2018-2023

Figure 54. By Type, Southeast Asia Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 55. By Application, Southeast Asia Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 56. India Biotech Drug Revenue, 2018-2029, (US$ Million)

Figure 57. By Company, India Biotech Drug Market Share, 2018-2023

Figure 58. By Type, India Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 59. By Application, India Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 60. Middle East & Asia Biotech Drug Revenue, 2018-2029, (US$ Million)

Figure 61. By Company, Middle East & Asia Biotech Drug Market Share, 2018-2023

Figure 62. By Type, Middle East & Asia Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 63. By Application, Middle East & Asia Biotech Drug Revenue Market Share, 2022 VS 2029

Figure 64. Research Methodology

Figure 65. Breakdown of Primary Interviews

Figure 66. Bottom-up Approaches

Figure 67. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)